Strongbridge Biopharma Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris
US Capital Global Facilitates $50MM Financing to Accelerate Charbone Hydrogen's North American Expansion
